NCT03798626 2026-04-01
Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers
Novartis
Phase 1 Completed
Novartis
Arcus Biosciences, Inc.
M.D. Anderson Cancer Center
Shanghai Junshi Bioscience Co., Ltd.